OxTalks is Changing
On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Cell-Based Gene Therapies for Cancer
In-Person Only
James S. Economou MD PhD is the Beaumont Distinguished Professor at the University of California Los Angeles, He has appointments in the Departments of Surgery; Microbiology, Immunology and Molecular Genetics; and Molecular and Medical Pharmacology. He is the senior surgical oncologist at UCLA, was the founding director of the UCLA Human Gene Medicine Program, and deputy director of the UCLA Jonsson Comprehensive Cancer Center. Dr. Economou was a scientific founder of Kite Pharma, His talk will provide an overview of technological trajectories and business models for cell-based gene therapies.
Date:
18 March 2025, 11:00
Venue:
MRC Weatherall Institute of Molecular Medicine, Headington OX3 9DS
Venue Details:
Seminar Room
Speakers:
Speaker to be announced
Organising department:
MRC Weatherall Institute of Molecular Medicine
Organisers:
Amanda Jarman (OSE),
Yasmine Saito (Weatherall Institute, University of Oxford)
Organiser contact email address:
ajarman@oxfordsciences.com
Host:
Prof Simon Davis (MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Yasmine Saito
